Dermatology has benefited enormously from advances in understanding the pathogenesis of skin diseases. In particular the recently introduced treatments with biologics have contributed to improve longterm safe control of inflammatory skin diseases but also innovative small molecules have improved care, such as new retinoids and immunostimulation for example. The implementation of innovations in dermatotherapy require specification to presentations of skin diseases in individual patients. In this issue of the Journal of Dermatological Treatment, several clinical observations will be presented.
Firstly a review on the effect of Behcets disease on vitamin levels will be presented.The efficacy of two biologics in a routine care will be presented, highlighting the efficacy in a subpopulation of high need patients with no options for classical non‐biologic treatments. Special attention will be given for treatment of psoriasis and seborrhoic dermatosis of the scalp. In this issue cutaneous Leishmaniasis and chronic furunculosis will be highlighted under ‘cutaneous infections’. Case reports in this issue will be on an original treatment for a frequent condition such as lichen simplex chronicus, but also succesful therapeutic possibilities for more seldom diseases will be presented: tufted angioma, facial granulomas following cosmetic implants, severe ichthyoses in children and acrokeratosis verruciformis of HOPF.
We hope that these clinical observations are of help for other colleagues and we invite you to submit case reports on observations which you have made.